MCL1 and cancer: Conversely, although the interaction of the APC/C with Mcl‐1 is likely to be normally sufficiently transient to not interfere with the recognition of other substrates such as cyclin B, there is the potential for this interaction to significantly affect APC/C function when its activity is limited or when Mcl‐1 is highly expressed, for instance in certain cancer cells.